Anticorps MeCP2

9 produits

MeCP2 est un gène codé par le symbole MECP2. Communément appelé aussi: Methyl-CpG-binding protein 2; MeCp-2 protein. MeCP2 a une masse de 52.44kDa, une longueur d'acide aminé de 486, et est impliqué dans les maladies: Angelman syndrome; Mental retardation, X-linked, syndromic, 13; Rett syndrome; Autism, X-linked 3; Encephalopathy, neonatal severe, due to MECP2 mutations; Mental retardation, X-linked, syndromic, Lubs type.

Nous proposons 9 des anticorps contre MeCP2, élevé dans Lapin, Souris et Poulet, qui sont appropriés pour le WB, IHC et ICC/IF avec des échantillons dérivés de Humain, Souris, Rat, Bovin, Porcin, Singe, Canin et Cheval.

Informations sur les Gènes et les Protéines

Résumé UniProt
Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC).
Résumé Entrez
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms.
Spécificité tissulaire
Present in all adult somatic tissues tested.
Implication dans la maladie
Angelman syndrome: A neurodevelopmental disorder characterized by severe motor and intellectual retardation, ataxia, frequent jerky limb movements and flapping of the arms and hands, hypotonia, seizures, absence of speech, frequent smiling and episodes of paroxysmal laughter, open-mouthed expression revealing the tongue.

Mental retardation, X-linked, syndromic, 13: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS13 patients manifest mental retardation associated with other variable features such as spasticity, episodes of manic depressive psychosis, increased tone and macroorchidism.

Rett syndrome: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood.

Autism, X-linked 3: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation.

Encephalopathy, neonatal severe, due to MECP2 mutations: A neurodevelopmental disorder characterized by severe neonatal encephalopathy, developmental delay, mental retardation, microcephaly, seizures. Additional features include respiratory insufficiency and central hypoventilation, gastroesophageal reflux, axial hypotonia, hyperreflexia and dyskinetic movements.

Mental retardation, X-linked, syndromic, Lubs type: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSL patients manifest mental retardation associated with variable features. They include swallowing dysfunction and gastroesophageal reflux with secondary recurrent respiratory infections, hypotonia, mild myopathy and characteristic facies such as downslanting palpebral fissures, hypertelorism and a short nose with a low nasal bridge.
Modification post-traductionnelle
Phosphorylated on Ser-423 in brain upon synaptic activity, which attenuates its repressor activity and seems to regulate dendritic growth and spine maturation.
Localisation cellulaire
Nucleus.

Colocalized with methyl-CpG in the genome. Colocalized with TBL1X to the heterochromatin foci.
Immunofluorescence - Anti-MeCP2 Antibody (A85427) - Antibodies.com
(4)
Voir le roduitTaille d'Essai de 10µl
Immunofluorescence - Anti-MeCP2 Antibody - Antibodies.com (A104323)
(2)
Voir le roduitTaille d'Essai de 10µl
Immunofluorescence - Anti-MeCP2 Antibody - Antibodies.com (A104324)
(2)
Voir le roduitTaille d'Essai de 10µl
Immunofluorescence - Anti-MeCP2 Antibody - Antibodies.com (A104322)
(2)
Voir le roduitTaille d'Essai de 10µl
Western Blot - Anti-MeCP2 Antibody (A87676) - Antibodies.com
(4)
Voir le roduitKO Validé
Western Blot - Anti-MeCP2 Antibody (A14913) - Antibodies.com
Anti-MECP2 Antibody from Bioworld Technology (BS7806) - Antibodies.com
Western blot - MECP2 Antibody from Signalway Antibody (32980) - Antibodies.com
Western blot - MeCP2 Antibody from Signalway Antibody (38000) - Antibodies.com

Affichage de 1-9 sur 9 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut